Sector: Pharmaceuticals & Biotechnology
|Small Cap
Rajnish Wellness Ltd.
₹0.45
₹0.45
₹0.47
Data is not available
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 23.24 | 12 | 4.56 | 5.77 | 9.06 |
| Operating Expense | 24.62 | 12.22 | 4.38 | 6.39 | 8.93 |
| Operating Profit | -1.37 | -0.22 | 0.18 | -0.61 | 0.13 |
| Depreciation | 0.01 | 0 | 0 | 0.01 | 0.01 |
| Interest | 0 | 0 | 0 | 0 | 0.04 |
| Tax | -0.10 | 0.02 | 0.08 | 0 | 0.02 |
| Net Profit | -0.91 | 0.06 | 0.22 | -0.46 | 0.07 |
₹0.45
↗ Bullish Moving Average
5
↘ Bearish Moving Average
11
Rajnish Wellness Limited, with its corporate operations in Mumbai, functions as a personal care and ayurvedic products company in India. The company manufactures and sells products including sexual wellness items, pharmaceutical goods, and consumer durables. Rajnish Wellness has a reach across domestic markets and sells its products through various e-commerce websites. The company operates under brand names including Play Win and Dava Discount.
Rajnish Wellness share price on NSE and BSE signifies how market participants react to the company’s operational performance and the overall developments in the consumer goods sector. The company’s financial health depends on product sales volumes, distribution network effectiveness, brand recognition, and the company’s ability to manage operational costs. Rajnish Wellness stock price gets influenced by various factors such as earnings reports, changes in consumer spending patterns, and trends in demand for ayurvedic and personal care products. In the longer run, strategies such as product portfolio expansion, e-commerce channel growth, and brand building affect the stock market sentiments. All these factors need monitoring to have an idea about the company’s stock price movements.
Rajnish Wellness live share price provides real-time information about the last price traded, bid and ask prices, and volume traded. These indicators represent market activity and liquidity, reflecting investor response to corporate announcements, economic conditions, and sector news. Constant monitoring of the Rajnish Wellness stock price movements helps in observing short term price volatility and shows how a stock moves relative to the broader consumer index. Furthermore, monitoring Rajnish Wellness live price helps investors understand real-time market sentiment, price fluctuations, and trading behaviour. It allows them to evaluate short-term performance and respond to news, quarterly results, or sector trends that may influence the company’s valuation.
Rajnish Wellness Limited was originally engaged in business activities under Quick Service Advertising before being incorporated as a corporate entity in 2015. The company was incorporated on 13 June 2015 as Rajnish Hot Deals Private Limited and later converted into a public limited company in 2018, following which it was renamed Rajnish Wellness Limited. The company is headquartered in Mumbai, Maharashtra. It operates in the wellness, ayurvedic, personal care, and pharmaceutical distribution segments. The company is listed on the BSE SME platform since 2018.
India’s ayurvedic, herbal, and wellness products industry is expanding steadily due to rising consumer preference for natural and plant-based personal care and healthcare products. Growth in this segment is supported by increasing awareness of preventive healthcare, expanding retail penetration in Tier II and Tier III cities, and growth of organized pharmacy and wellness retail networks. The sexual wellness segment is also gradually expanding, supported by increasing e-commerce adoption and improved accessibility of private-label wellness products. The pharmaceutical retail franchise model has seen growth in semi-urban and rural areas, driven by demand for accessible and affordable healthcare products. Within this environment, Rajnish Wellness Limited operates as a branded wellness and distribution-focused company with exposure to ayurvedic, personal care, and retail pharmaceutical segments.
Rajnish Wellness Limited is listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). Rajnish Wellness share price is available for trading on the BSE under the scrip code 541601 . The company’s market presence is primarily within the small-cap segment of the market . Due to its size and sector focus, Rajnish Wellness stock price is generally tracked by investors interested in the personal care and ayurvedic products industry.
Rajnish Wellness is part of several broad-based and sector-specific stock market indices, reflecting its position as a small-cap consumer company in India. Rajnish Wellness share price was added to the S&P Global BMI Index in September 2023, reflecting its growing international recognition . In addition, the company is included in multiple BSE indices which capture companies across small and mid-cap segments.
Rajnish Wellness share price on NSE reflects its status as a personal care and sexual wellness products company with a focus on ayurvedic formulations in India. Performance gets driven by factors like product sales growth, distribution expansion, brand recognition, and the company’s ability to manage operational costs effectively. Investors compare Rajnish Wellness share price today with other consumer goods companies to gauge relative performance within the sector.
These underlying factors often appear through real market movements across different periods. Broader sector strength has played a role in supporting Rajnish Wellness share price. In addition to operational and sector-led factors, corporate actions such as the name change from Rajnish Hot Deals Limited to Rajnish Wellness Limited in 2018 can also have a significant impact on Rajnish Wellness share price movements . This shows how corporate actions can trigger brand perception changes, even within a competitive consumer goods framework influenced by spending cycles and regulatory policies.
While short-term movements reflect events and announcements, longer-term valuation trends become visible through Rajnish Wellness share price 52-week high and low, providing context beyond daily or weekly changes. Highs indicate strong product demand and stable margins, while lows align with market corrections or sector volatility. These levels capture the impacts of government policies, consumer spending, and earnings visibility, providing context for the stock’s historical performance.
Rajnish Wellness stock performance reflects the trading behaviour of a small-cap consumer company operating within India’s competitive personal care landscape. The company’s operations across ayurvedic medicines, sexual wellness products, and pharmaceutical goods have shaped its Rajnish Wellness share price history. Over time, the stock has shown periods of growth and phases of consolidation. The company was founded in 2009 and has expanded its product portfolio significantly over the years .
Rajnish Wellness stock performance over time has closely followed India’s consumer spending cycles and wellness product demand trends. The company sells its products through various e-commerce websites, including snapdeal.com, indiamart.com, and clickoncare.com . Over longer investment horizons, the stock has delivered mixed returns, with a five-year return showing positive growth but significant declines in recent years . The stock reached a 52-week high at a certain level and a 52-week low at a different level, reflecting the volatility inherent in the consumer products business .
Despite COVID-19 disruptions, Rajnish Wellness shares showed resilience during certain periods. While the broader economy faced challenges with lockdowns and reduced economic activity, the company’s focus on wellness and personal care products helped maintain operations. The company’s digital sales channels continued to serve customers remotely during the pandemic period.
Rajnish Wellness share price has seen decreases due to several recurring reasons. A decline in product sales or a slowdown in distribution expansion directly impacts revenue and leads to selling pressure. Changes in government policy, such as alterations in ayurvedic product regulations or changes in e-commerce rules, can also cause the stock to fall. Furthermore, any increase in operational costs like raw material procurement costs or marketing expenses without a matching rise in sales squeezes the company’s margins, making the stock less attractive. Periods of economic slowdown that reduce consumer spending on wellness products raise concerns about revenue growth, leading to a drop in Rajnish Wellness share price. The stock is also sensitive to competitive intensity in the personal care space; if rival companies gain market share through aggressive marketing, it can lead to a decrease in Rajnish Wellness stock price as investors adjust expectations for future revenue growth. Broader market sell-offs in small-cap consumer stocks also pull the price down, regardless of the company’s individual performance. The company posted a net loss of over zero point nine crore rupees for the quarter ended December 2025, which directly affected market sentiment and contributed to a decrease in Rajnish Wellness share price . A decrease in PlayWin brand sales or lower pharmaceutical product distribution directly hurts the company’s revenue, resulting in a lower valuation for Rajnish Wellness share price.
Rajnish Wellness is a holding in consumer and small-cap portfolios, offering exposure to ayurvedic products, sexual wellness items, and pharmaceutical goods. Inclusion in small-cap indices underscores its importance in India’s personal care space. The company’s focus on wellness products and its e-commerce distribution model make it a consideration for long-term allocations.
Rajnish Wellness equity is held by a broad mix of promoters and public shareholders, reflecting its standing in India’s consumer sector. Promoter holding stands at around nine point two percent, with Mr. Rajnishkumar Surendra Prasad Singh serving as the Executive Chairman and Managing Director . Retail investors hold approximately eighty five percent of the company’s shares, while foreign portfolio investors hold around zero point four three percent . This broad investor base with significant retail participation underscores the company’s role as a holding in both domestic and global portfolios focused on consumer products.
Beyond fundamentals and ownership, Rajnish Wellness share price is actively monitored by market participants. The stock is available for trading on the BSE, and market participants watch price movements to gauge sentiment around quarterly results and policy announcements. The company has only seventeen full-time employees as of the latest reporting period .
Technical indicators such as RSI, MACD, and MFI provide additional insight into short-term momentum shifts in the company’s stock price. While these indicators are primarily used for near-term trading decisions, they also help investors and portfolio managers understand broader market sentiment and anticipate potential volatility, especially around key events or announcements.
Rajnish Wellness stock price has exhibited certain volatility patterns. Rajnish Wellness beta has generally remained at levels reflecting its position as a small-cap consumer stock with significant retail participation and business fundamentals tied to consumer spending cycles. The stock has shown a negative correlation with broader market movements in certain periods. Over shorter timeframes, the stock has shown relatively higher sensitivity to market movements, indicating short-term volatility. During the three-month period, this sensitivity appears more balanced, suggesting a stable trading pattern. Across longer durations, the beta trends in a manner indicating continued correlation with overall market fluctuations. This behaviour is typical for companies in the personal care sector with exposure to discretionary consumer spending. Overall, these variations across different timeframes highlight that while Rajnish Wellness may experience short-term fluctuations, its longer-term volatility remains characteristic of a small-cap consumer stock.
Rajnish Wellness sector relevance stems from its scale in ayurvedic product manufacturing and its presence across sexual wellness, pharmaceutical goods, and personal care segments. Peer comparisons with companies like Aarti Drugs, Aarti Pharmalabs, and Abbott India focus on product portfolio, distribution reach, brand recognition, and geographical presence rather than short-term stock moves. These benchmarks help investors assess operational scale, efficiency, and regulatory adherence. Institutional tracking of consumer spending, ayurvedic product demand, and competitive dynamics further highlights Rajnish Wellness positioning within India’s broader personal care market.
Rajnish Wellness market cap history shows the company’s position within the consumer goods sector. Since its transition from a teleshopping venture to a public limited company, the market capitalization has grown as the company established its wellness product portfolio. The company’s focus on sexual wellness and its flagship PlayWin brand contributed to a re-evaluation by the market. This transition from a small teleshopping operation to a branded wellness products company has been a key factor in how the company’s overall valuation has evolved over time. The company currently maintains a market capitalization in the small-cap range .
Rajnish Wellness earnings history demonstrates the impact of its strategic business decisions and external market conditions. In the financial year 2025, the company reported total revenue of over forty eight crore rupees, with profit after tax of over zero point one seven crore rupees . The company’s revenue declined from over seventy six crore rupees in the financial year 2024 to over forty eight crore rupees in the financial year 2025 . For the quarter ended December 2025, the company reported a net loss of over zero point nine one crore rupees, reflecting margin pressures and reduced demand . The company’s net profit margin for the trailing twelve months stood at negative levels .
Rajnish Wellness EPS provides insight into its operational performance and income generation from ayurvedic product sales and pharmaceutical distribution. Over the years, earnings per share have shown variation in line with the company’s business cycle and industry conditions. The company’s focus on building its PlayWin brand and expanding its e-commerce presence has influenced the EPS trajectory. Quarterly performance reflects the ongoing earnings from product sales, with the sexual wellness segment contributing to the overall per-share earnings picture. The company’s basic earnings per share for the trailing twelve months was reported at negative levels .
Rajnish Wellness P/E ratio reflects how investors perceive the company’s earnings relative to its business model. The company’s price-to-earnings ratio has been not applicable due to negative earnings in the trailing twelve months . This ratio has moved in response to how investors view the company’s prospects in areas like brand expansion and e-commerce growth. The company’s P/B ratio was reported at zero point four four times, indicating a discount to its book value . These changes highlight how market sentiment has evolved alongside the company’s business transformation and expansion strategy.
Rajnish Wellness Limited manufactures and sells ayurvedic personal care products, sexual wellness items, and pharmaceutical goods through e-commerce channels. Rajnish Wellness share price on the NSE and BSE reflects trading activity within the personal care and consumer products industry. The company has a notable presence in domestic markets. Rajnish Wellness stock price is influenced by consumer spending, product demand, operational costs, and broader economic factors. The company’s focus on wellness products and e-commerce distribution remains a key aspect of its business profile.
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 7.4 | 7.4 | 7.4 | 9.2 | 9.2 | 9.2 |
| FII | 0 | 0.6 | 0.6 | 0.4 | 0.4 | 0.4 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 92.6 | 92 | 92 | 90.4 | 90.4 | 90.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 13.02 L | 22.41 L | 58.09% |
| Week | 14.42 L | 31.13 L | 46.32% |
| 1 Month | 29.08 L | 33.06 L | 87.96% |
| 6 Month | 40.69 L | 71.95 L | 56.55% |
PEG lower than Industry PEG
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Top Gainers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹46.26 | ₹492.90 | ₹219.30 | ₹252.10 | ₹38.27 | ₹6.40 |
| % Change | -4.99% | 1.27% | 4.95% | -4.14% | 4.99% | -2.14% |
| Revenue TTM (₹ Cr) | - | - | - | - | ₹1.27 | ₹83.60 |
| Net Profit TTM (₹ Cr) | - | - | - | - | ₹-0.25 | ₹-34.95 |
| PE TTM | 15.70 | - | 22.40 | 36.00 | -90.60 | -1.50 |
| 1 Year Return | 24.95 | 750.44 | 544 | |||
| ROCE | - | 3.56 | - | - | - | -5.63 |
Aptus Pharma Ltd.
₹ 179.50
-1.37%
Amanta Healthcare Ltd.
₹ 131.01
+0.71%
Anlon Healthcare Ltd.
₹ 13.79
-0.86%
Patel Chem Specialities Ltd.
₹ 87.00
-4.05%
Asston Pharmaceuticals Ltd.
₹ 72.80
+0.00%
Amrutanjan Health Care Ltd.
₹ 559.75
+0.46%
Astonea Labs Ltd.
₹ 231.00
+1.76%
Amwill Health Care Ltd.
₹ 32.38
+4.96%
Innova Captab Ltd.
₹ 852.80
+0.53%
Valiant Laboratories Ltd.
₹ 78.00
+1.46%
Shelter Pharma Ltd.
₹ 30.63
-0.07%
Trident Lifeline Ltd.
₹ 254.00
+2.13%
Dipna Pharmachem Ltd.
₹ 7.47
-0.66%
Achyut Healthcare Ltd.
₹ 5.83
+2.64%
Sigachi Industries Ltd.
₹ 20.34
-0.05%
Windlas Biotech Ltd.
₹ 784.40
-0.70%
Vineet Laboratories Ltd.
₹ 35.00
-1.69%
Chandra Bhagat Pharma Ltd.
₹ 40.00
+5.26%
Solara Active Pharma Sciences Ltd.
₹ 556.00
+1.44%
Zim Laboratories Ltd.
₹ 99.45
-0.71%
Bharat Parenterals Ltd.
₹ 1374.35
-0.69%
Medico Remedies Ltd.
₹ 48.93
+2.28%
By signing up I certify terms, conditions & privacy policy